WPI Assistant Professor Nitin Sanket has received a $704,908 National Science Foundation (NSF) Foundational Research in Robotics grant to develop sound-based navigation systems that enable tiny aerial robots to operate in environments where cameras and light sensors fail, such as smoke, dust, or darkness. Drawing inspiration from how bats use echolocation, Sanket’s project combines bio-inspired design, deep learning, and sensor fusion to create lightweight, energy-efficient drones capable of autonomous navigation in challenging conditions—advancing robotics for applications in disaster response, environmental monitoring, and search and rescue.

Researchers at Brown University found that AI chatbots routinely violate core mental health ethics standards, underscoring the need for legal standards and oversight as use of these tools increases.

On October 2, the third edition of Insilico Medicine’s Pharma.AI Quarterly Launch webinar—titled “Towards Pharmaceutical Superintelligence” —was successfully closed with around 300 registrants all over the world from universities, healthcare institutions, international pharmaceutical companies, and the innovative biotech industry. During the webinar, Insilico software team illustrated the most up-to-date abilities of the Pharma.AI platform while presenting live demos as well as case studies, and the highlights are summarized as below.

Researchers at the HUN-REN Biological Research Centre, Szeged, Hungary, have developed an artificial-intelligence-assisted technology capable of analyzing up to one hundred patient-derived cell samples simultaneously.

The new method, described in Nature Communications, could significantly accelerate drug development and advance the field of personalized medicine.

Researchers at the HUN-REN Biological Research Centre in Szeged, Hungary, have developed an artificial-intelligence-assisted technology capable of analyzing up to one hundred patient-derived cell samples simultaneously.

The new method, described in Nature Communications, could significantly accelerate drug development and advance the field of personalized medicine.